• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化疗在晚期不可切除头颈部鳞状细胞癌的多学科综合治疗——放射治疗计划中的整合

Integration of chemotherapy in an MFD--radiotherapy plan for advanced inoperable squamous cell carcinoma of the head and neck.

作者信息

Corvò R, Merlano M, Looney W B, Benasso M, Bacigalupo A, Margarino G

机构信息

Department of Radiotherapy, Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy.

出版信息

Head Neck. 1990 Jan-Feb;12(1):60-5. doi: 10.1002/hed.2880120108.

DOI:10.1002/hed.2880120108
PMID:2298565
Abstract

From January 1987 to May 1988, 16 patients with advanced squamous cell carcinoma of the head and neck received combined treatment, based on an alternating schedule of chemotherapy and multiple fractions per day (MFD)-radiotherapy. The chemotherapy regimen consisted of cisplatin, 20 mg/m2, followed by 5-fluorouracil (5-FU), 200 mg/m2 i.v. push, from days 1 to 5 during weeks 1, 5, and 9. Radiotherapy was administered in two courses of 32 Gy each (total dose, 64 Gy) during weeks 2 and 3 and 6 and 7. Each course was given in two fractions per day, 5 days per week. The 16 patients were evaluated for toxicity and response. We observed 7 complete responders, 6 partial responders, and 3 nonresponders. The overall response rate was 81%. Toxicity was heavy: 44% of the patients developed grade III-IV mucositis. Our results suggest that cisplatin and 5-fluorouracil alternating with MFD-radiotherapy is effective; however, a new less toxic scheduling must be determined.

摘要

1987年1月至1988年5月,16例晚期头颈部鳞状细胞癌患者接受了联合治疗,治疗方案为化疗与每日多次分割放疗(MFD)交替进行。化疗方案为顺铂,20mg/m²,随后是5-氟尿嘧啶(5-FU),200mg/m²静脉推注,于第1、5、9周的第1至5天给药。放疗在第2和3周以及第6和7周分两个疗程进行,每个疗程32Gy(总剂量64Gy)。每个疗程每天分两次给药,每周5天。对这16例患者进行了毒性和疗效评估。我们观察到7例完全缓解者、6例部分缓解者和3例无反应者。总缓解率为81%。毒性反应严重:44%的患者出现III-IV级粘膜炎。我们的结果表明,顺铂和5-氟尿嘧啶与MFD放疗交替使用是有效的;然而,必须确定一种毒性较小的新方案。

相似文献

1
Integration of chemotherapy in an MFD--radiotherapy plan for advanced inoperable squamous cell carcinoma of the head and neck.化疗在晚期不可切除头颈部鳞状细胞癌的多学科综合治疗——放射治疗计划中的整合
Head Neck. 1990 Jan-Feb;12(1):60-5. doi: 10.1002/hed.2880120108.
2
[Alternating chemotherapy and daily multiple-fraction radiotherapy in the treatment of advanced spinocellular carcinoma of the head and neck].[交替化疗与每日多次分割放疗治疗晚期头颈部棘细胞癌]
Acta Otorhinolaryngol Ital. 1989 Jan-Feb;9(1):25-32.
3
Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.局部晚期头颈癌治疗中快速交替化疗与超分割放疗:一项I/II期研究的四年结果
J Clin Oncol. 1994 Sep;12(9):1876-85. doi: 10.1200/JCO.1994.12.9.1876.
4
Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.顺铂、氟尿嘧啶和亚叶酸钙诱导化疗后联合顺铂同步放化疗用于晚期头颈癌患者的器官保留及治愈:长期随访
J Clin Oncol. 2004 Aug 1;22(15):3061-9. doi: 10.1200/JCO.2004.01.108.
5
Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol.超分割放疗联合5-氟尿嘧啶、顺铂和紫杉醇(泰素)治疗Ⅲ期和Ⅳ期不可手术和/或无法切除的头颈部鳞状细胞癌的耐受性和疗效的Ⅱ期研究:A-2方案
Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):942-7. doi: 10.1016/s0360-3016(02)02816-x.
6
Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy.采用化疗与放疗交替的方法治疗晚期头颈部鳞状细胞癌。
N Engl J Med. 1992 Oct 15;327(16):1115-21. doi: 10.1056/NEJM199210153271602.
7
Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.顺铂、5-氟尿嘧啶、甲氨蝶呤和亚叶酸钙联合化疗(PFML)及放疗治疗局部晚期头颈部鳞状细胞癌的疗效和毒性分析
Cancer Chemother Pharmacol. 2007 May;59(6):789-94. doi: 10.1007/s00280-006-0335-1. Epub 2006 Oct 20.
8
Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.晚期头颈部鳞状细胞癌诱导化疗后同步放化疗:多西他赛、顺铂和5-氟尿嘧啶II期研究的四年随访最终结果
Oral Oncol. 2006 Aug;42(7):675-84. doi: 10.1016/j.oraloncology.2005.12.006. Epub 2006 May 30.
9
Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck.一项关于头颈部不可切除鳞状细胞癌的随机试验的五年随访结果:交替放疗与化疗联合方案与单纯放疗方案的比较
J Natl Cancer Inst. 1996 May 1;88(9):583-9. doi: 10.1093/jnci/88.9.583.
10
Alternating cisplatin-5-fluorouracil and radiotherapy in head and neck cancer.
Am J Clin Oncol. 1988 Oct;11(5):538-42. doi: 10.1097/00000421-198810000-00006.